MAIA Biotechnology (MAIA) Institutional Ownership $2.13 -0.26 (-10.88%) (As of 11/14/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort Interest Institutional Ownership Changes (13F Filings) for MAIA Biotechnology (NYSEAMERICAN:MAIA)CurrentInstitutional OwnershipPercentage5.65%Number ofInstitutional Buyers(last 12 months)3Number ofInstitutional Sellers(last 12 months)0 Get MAIA Insider Trade Alerts Want to know when executives and insiders are buying or selling MAIA Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MAIA Institutional Buying and Selling by Quarter Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. MAIA Biotechnology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/8/2024 Ground Swell Capital LLC16,460$56K0.0%N/A0.075% 7/9/2024 Mather Group LLC.12,060$41K0.0%+50,150.0%0.055% 5/20/2024Virtu Financial LLC32,487$71K0.0%N/A0.149% 10/10/2023FNY Investment Advisers LLC17,550$38K0.0%N/A0.129% 7/20/2023 Naviter Wealth LLC22,168$49K0.0%N/A0.163% 2/7/2023Lynwood Capital Management Inc.250,000$878K1.1%+25.1%2.283% 1/4/2023Centric Wealth Management40,206$141K0.1%N/A0.367% (Data available from 1/1/2016 forward) MAIA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MAIA shares? During the previous two years, the following institutional investors and hedge funds held shares of MAIA Biotechnology shares: Lynwood Capital Management Inc. ($878K), Centric Wealth Management ($141K), Virtu Financial LLC ($71K), Ground Swell Capital LLC ($56K), Naviter Wealth LLC ($49K), and Mather Group LLC. ($41K), and FNY Investment Advisers LLC ($38K).Learn more on MAIA's institutional investors. What percentage of MAIA Biotechnology stock is owned by institutional investors? 5.65% of MAIA Biotechnology stock is owned by institutional investors. Learn more on MAIA's institutional investor holdings. Which institutional investors have been buying MAIA Biotechnology stock? The following institutional investors have purchased MAIA Biotechnology stock in the last 24 months: Lynwood Capital Management Inc. ($50.22K), Centric Wealth Management ($40.21K), Virtu Financial LLC ($32.49K), Naviter Wealth LLC ($22.17K), FNY Investment Advisers LLC ($17.55K), Ground Swell Capital LLC ($16.46K), and Mather Group LLC. ($12.04K). How much institutional buying is happening at MAIA Biotechnology? Institutional investors have bought a total of 191,122 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Related Companies CMPX Major Shareholders ATAI Major Shareholders INZY Major Shareholders OPT Major Shareholders INBX Major Shareholders ETON Major Shareholders CYBN Major Shareholders TRVI Major Shareholders FULC Major Shareholders AMRN Major Shareholders This page (NYSEAMERICAN:MAIA) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MAIA Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MAIA Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
